Breaking News
Top News
-
Lumin Wealth buys London-based Gresham Financial Strategies
-
Sara-Bay Financial Makes Big Bet on MercadoLibre, Adds $12 Million Worth of Stock
-
Why This $59 Million MercadoLibre Buy Follows a 12% Stock Drop
-
Market Indexes Surge: Nasdaq 100 Up 5.9% for the Week on Hormuz News
-
Oracle—and Other Beaten-Down Tech Stocks—Surge in Latest Market Rally
-
Better Pharma Dividend Stock: Novartis vs. Merck
-
Should You Chase the 15% Rally in MicroStrategy Stock Today?
-
Nat-Gas Prices Rise on Expectations of Hot US Temps to Boost Air-Conditioning
-
Pershing Square USA IPO: What Is the PSUS Stock IPO Price Range and IPO Date? And Should You Buy Shares?
-
Crude Oil Prices Plummet as the Strait of Hormuz Reopens
-
Taroom: Australia’s new oil play
-
Dollar Drops on Middle East Peace Optimism
-
How to Invest $2,000: Investment Opportunities and Examples
-
Exclusive-Meta targets May 20 for first wave of layoffs; additional cuts later in 2026
-
3 Reasons to Buy Oracle Stock as the AI Trade Gets Riskier
-
Australia’s Victoria State Extends Public Transport Benefits
-
US Coast Guard spots overturned vessel near Saipan during search for missing ship
-
RBC Trims Becton Dickinson (BDX) Outlook despite Stable MedTech Demand
-
UBS Raises Merck (MRK) Price Forecast as Part of Sector Preview
-
UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400
2026-02-05
































